MTOR and non-small cell lung carcinoma: We found that canagliflozin mediated activation of AMPK, inhibition of ACC and the mTOR‐HIF‐1α pathway, and an associated suppression of the mitosis marker, p‐H3Ser10, in NSCLC cells.